ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Translational Session

Onconephrology: Focus on Hematology

November 03, 2023 | 02:00 PM - 04:00 PM

Location: Room 201, Pennsylvania Convention Center

Session Description

Onconephrology crosses into many areas, including hematology. Kidney diseases occur from a number of hematologic malignancies and drugs that are administered to patients. Thrombotic microangiopathy develops from a number of medications and cancers. There are a number of kidney lesions that result from lymphomas and leukemias, which can present acutely with aggressive disease of quite indolently. Monoclonal light chains cause various forms of kidney injury, with the tubulointerstitium as an important target. Diagnosis and management of amyloid light chain (AL) amyloidosis-related kidney injury is an important area of competence for onconephrologists. This session covers these important topics in kidney care.

Learning Objective(s)

  • Describe the drugs and cancers that cause thrombotic microangiopathy
  • Characterize the various renal complications of leukemias and lymphomas
  • Define the clinical aspects of light chain-related tubulointerstitial disease
  • Articulate the diagnosis and treatment of AL amyloidosis with kidney involvement

Learning Pathway(s)

  • Onconephrology